Browsing: Beyond

Health experts have described obesity as a chronic disease and called for a shift away from the traditional “eat less, exercise more” approach, urging treatment to be tailored to an individual’s health needs and disease severity

The scale had little to complain about. When Manish Arora was 60 years he weighed 81.6 kg. His BMI was 25.4—hardly a number that would set off alarm bells. His waist, however, measured 106 cm. He had lived with type 2 diabetes for a decade and had already had a heart attack. After treatment, his…

An oral small molecule that increases energy expenditure rather than suppressing appetite produced substantial weight loss while preserving lean mass in mouse models of obesity, suggesting a potentially complementary strategy to GLP-1–based therapies

For many people taking GLP-1 weight loss medications, the physical changes can be significant. But those changes can also bring unexpected challenges to a relationship

As GLP-1 medications transform obesity care, researchers are testing new hormone combinations aimed at improving weight loss, tolerability, and long-term outcomes.

A workplace is often judged by how it looks — the furniture, lighting, open spaces, breakout zones and curated interiors. But as the relationship between people and workplaces evolves, the real measure of a good office goes beyond aesthetics. It lies in a more fundamental question: does the environment help people feel better, work better…

For years, going out in Acadiana often meant meeting friends at a restaurant, grabbing a drink at a bar or finding a table somewhere with live music. 

The term “Ozempic babies” has been circulating on social media after women taking GLP-1 medications reported unexpected pregnancies

Health plans are being asked to solve for total cost of care across a growing set of overlapping conditions — obesity, diabetes, hypertension, cholesterol, and multi-condition members at the intersection of all of them. GLP-1 utilization has intensified the pressure, surfacing sustainability questions that no single-condition vendor is positioned to answer on its own. This…

From treating health-related conditions to weight loss, the GLP-1 landscape is rapidly expanding